SLC30A3 and Alzheimer disease: This approach revealed SLC30A3 as a zinc transporter downregulated in AD brain tissue, which exhibited robust predictive power (AUC = 0.70–0.80) across multiple cohorts, suggesting its potential as a novel diagnostic biomarker.